HOOKIPA Pharma Inc. / Fundamentals
Income statement
- Net revenue
€8.07M - Cost of goods sold
€603.26K - Gross profit
€7.47M - SG&A expenses
€19.90M - R&D expenses
€52.82M - EBITDA
-€61.20M - D&A
€2.16M - EBIT
-€69.42M - Interest expenses
€0.00 - EBT
-€63.36M - Tax expenses
-€91.48K - Net income
-€63.27M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€31.42M - Changes in working capital
€32.41M - Operating cash flow
-€45.54M - Capex
€84.58K - Other investing cash flow
€0.00 - Net investing cash flow
-€84.58K - Total cash dividends paid
€0.00 - Issuance of common stock
€116.51K - Debt repayment
€0.00 - Other financing cash flow
-€984.72K - Net financing cash flow
-€984.72K - Foreign exchange effects
€1.32M - Net change in cash
-€45.29M - Cash at end of period
€34.94M - Free cash flow
-€45.46M
Balance sheet
- Cash and cash equivalents
€34.76M - Cash and short-term investments
€34.76M - Total receivables
€470.35K - Inventory
€0.00 - Other current assets
€16.63M - Total current assets
€51.86M - Property, plant & equipment
€592.04K - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€0.00 - Other non-current assets
€413.39K - Total non-current assets
€1.01M - Total assets
€52.87M - Accounts payable
€3.17M - Short-term debt
€269.27K - Other current liabilities
€4.62M - Total current liabilities
€14.36M - Long-term debt
€245.10K - Deferred tax liabilities
€0.00 - Other non-current liabilities
€8.85M - Total non-current liabilities
€9.10M - Total liabilities
€23.45M - Common stock
€863.04 - Retained earnings
-€369.54M - Other equity
-€5.56M - Total equity
€0.00 - Total liabilities and shareholders' equity
€52.87M
Company information
- Market capitalization
€13.00M - Employees
82 - Enterprise Value
-€21.64M
Company ratios
- Gross margin
-
92.5% Much better than peer group: -12,768.0% - EBITDA margin
-
-758.4% Much better than peer group: -1,788,344.0% - EBIT margin
-
-860.2% Much better than peer group: -1,800,971.1% - EBT margin
-
-785.1% Much better than peer group: -1,796,925.2% - Net margin
-
-784.0% Much better than peer group: -1,723,697.6% - ROE
-
0.0% - ROA
-
-119.7% Much worse than peer group: -50.9% - Asset turnover
-
15.3% Better than peer group: 4.4% - FCF margin
-
-565.4% Much better than peer group: -1,410,550.3% - FCF yield
-350.9% - Efficiency ratio
858.4% - Net sales per employee
-
€98.42K - Net income per employee
-
-€771.61K